SCA
BMY icon

STALEY CAPITAL ADVISERS’s Bristol-Myers Squibb BMY Stock Holding History

STALEY CAPITAL ADVISERS’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,589
Closed -$423K – 148
2019
Q4 		$423K Buy
6,589
+525
+9% +$30.1K 0.03% 127
2019
Q3 		$308K Sell
6,064
-570
-9% -$26.8K 0.02% 135
2019
Q2 		$301K Buy
6,634
+29
+0.4% +$1.35K 0.02% 135
2019
Q1 		$315K Buy
6,605
+91
+1% +$4.53K 0.02% 132
2018
Q4 		$339K Buy
6,514
+26
+0.4% +$1.4K 0.03% 123
2018
Q3 		$403K Buy
6,488
+22
+0.3% +$1.31K 0.03% 117
2018
Q2 		$358K Buy
6,466
+625
+11% +$33.8K 0.03% 125
2018
Q1 		$369K Sell
5,841
-980
-14% -$63K 0.03% 112
2017
Q4 		$418K Sell
6,821
-980
-13% -$61.3K 0.03% 107
2017
Q3 		$497K Buy
7,801
+817
+12% +$47.7K 0.04% 105
2017
Q2 		$389K Buy
6,984
+22
+0.3% +$1.2K 0.03% 113
2017
Q1 		$379K Buy
6,962
+24
+0.3% +$1.32K 0.03% 99
2016
Q4 		$405K Buy
6,938
+24
+0.3% +$1.31K 0.04% 91
2016
Q3 		$373K Buy
6,914
+227
+3% +$14.6K 0.04% 92
2016
Q2 		$492K Buy
6,687
+16
+0.2% +$1.13K 0.05% 78
2016
Q1 		$426K Buy
6,671
+20
+0.3% +$1.26K 0.05% 79
2015
Q4 		$458K Buy
6,651
+17
+0.3% +$1.12K 0.05% 80
2015
Q3 		$393K Sell
6,634
-518
-7% -$32.9K 0.05% 88
2015
Q2 		$476K Buy
7,152
+2,017
+39% +$133K 0.05% 85
2015
Q1 		$331K Hold
5,135
– – 0.04% 94
2014
Q4 		$303K Hold
5,135
– – 0.04% 97
2014
Q3 		$263K Hold
5,135
– – 0.03% 108
2014
Q2 		$249K Hold
5,135
– – 0.03% 112
2014
Q1 		$267K Sell
5,135
-1,524
-23% -$81.1K 0.03% 110
2013
Q4 		$354K Hold
6,659
– – 0.05% 91
2013
Q3 		$308K Buy
+6,659
New +$292K 0.05% 90

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

STALEY CAPITAL ADVISERS's BMY Position: Q1 2020 in Review

STALEY CAPITAL ADVISERS sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 6,589 shares — an estimated $423K sold.

STALEY CAPITAL ADVISERS first reported a position in BMY in Q3 2013 and held it in 26 quarters. The position peaked at $497K in Q3 2017. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • STALEY CAPITAL ADVISERS reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
  • STALEY CAPITAL ADVISERS sold 6,589 Bristol-Myers Squibb shares in Q1 2020, an estimated $423K.
  • STALEY CAPITAL ADVISERS first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 26 quarters.
  • STALEY CAPITAL ADVISERS's Bristol-Myers Squibb position peaked at $497K in Q3 2017.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q1 2020, filed 8 May 2020.